Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over 75-years-old ...

With respiratory illness season at its peak, the latest CDC data shows a significant rise in flu cases nationwide, while ...

Age-related changes that impact the immune system — plus underlying chronic health issues that become more common with age — put older adults at higher risk for serious complications from respiratory ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

Citation: Symptoms of viral influenza, COVID-19, norovirus, and RSV can be signs of potential heart complications, warn experts (2025, January 24) retrieved 6 February 2025 from https ...

respiratory syncytial virus (RSV) and other respiratory viruses, it’s critical to pay close attention to your heart and symptoms, cardiology experts warn. “Some patients may think that ...

there is no specific treatment for RSV in adults. Instead, managing the virus focuses on relieving symptoms and supportive care as the main treatment for acute infection which involves using ...

Adults who were assessed for signs and symptoms of acute respiratory disease and tested for RSV via reverse transcriptase-polymerase chain reaction (RT-PCR) in Rochester, New York were eligible for ...

Abrysvo was first approved on May 31, 2023, for prevention of lower respiratory tract disease (LRTD) associated with RSV in adults aged 60 years or more, and has since been approved for the same ...

For those 60 and older or for people who are pregnant, you may want to get the RSV vaccine ... Humidifiers can help with symptoms, too. There’s no medication for norovirus.

GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the shot hit the mark in the much-anticipated AReSVi 006 trial in adults ...